Clinical course of gamma-hydroxybutyrate overdose
- PMID: 9624311
Clinical course of gamma-hydroxybutyrate overdose
Abstract
Study objective: To describe the clinical characteristics and course of gamma-hydroxybutyrate (GHB) overdose.
Methods: We assembled a retrospective series of all cases of GHB ingestion see in an urban public-hospital emergency department and entered in a computerized database January 1993 through December 1996. From these cases we extracted demographic information, concurrent drug use, vital signs, Glasgow Coma Scale (GCS) score, laboratory values, and clinical course.
Results: Sixty-one (69%) of the 88 patients were male. The mean age was 28 years. Thirty-four cases (39%) involved coingestion of ethanol, and 25 (28%) involved coingestion of another drug, most commonly amphetamines. Twenty-five cases (28%) had a GCS score of 3, and 28 (33%) had scores ranging from 4 through 8. The mean time to regained consciousness from initial presentation among nonintubated patients with an initial GCS of 13 or less was 146 minutes (range, 16-389). Twenty-two patients (31%) had an initial temperature of 35 degrees C or less. Thirty-two (36%) had asymptomatic bradycardia; in 29 of these cases, the initial GCS score was 8 or less. Ten patients (11%) presented with hypotension (systolic blood pressure < or = 90 mm Hg); 6 of these patients also demonstrated concurrent bradycardia. Arterial blood gases were measured in 30 patients; 21 had a PCO2 of 45 or greater, with pH ranging from 7.24 to 7.34, consistent with mild acute respiratory acidosis. Twenty-six patients (30%) had an episode of emesis; in 22 of these cases, the initial GCS was 8 or less.
Conclusion: In our study population, patients who overdosed on GHB presented with a markedly decreased level of consciousness. Coingestion of ethanol or other drugs is common, as are bradycardia, hypothermia, respiratory acidosis, and emesis. Hypotension occurs occasionally. Patients typically regain consciousness spontaneously within 5 hours of the ingestion.
Comment in
-
gamma-Hydroxybutyrate intoxication and overdose.Ann Emerg Med. 1999 Apr;33(4):475-6. Ann Emerg Med. 1999. PMID: 10092734 No abstract available.
-
The use of physostigmine in the management of gamma-hydroxybutyrate overdose.Ann Emerg Med. 2001 Sep;38(3):347-8. Ann Emerg Med. 2001. PMID: 11547795 No abstract available.
Similar articles
-
Clinical Course of γ-Hydroxybutyrate Overdose.Ann Emerg Med. 1998 Jun;31(6):716-722. Ann Emerg Med. 1998. PMID: 28140165
-
Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.Clin Toxicol (Phila). 2007 Jun-Aug;45(5):533-8. doi: 10.1080/15563650701365818. Clin Toxicol (Phila). 2007. PMID: 17503262
-
Gamma-hydroxybutyrate: a 30 month emergency department review.Emerg Med Australas. 2008 Dec;20(6):521-30. doi: 10.1111/j.1742-6723.2008.01140.x. Emerg Med Australas. 2008. PMID: 19125832
-
[Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].Ugeskr Laeger. 1999 Dec 13;161(50):6903-7. Ugeskr Laeger. 1999. PMID: 10643375 Review. Danish.
-
Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.Clin Toxicol (Phila). 2008 Aug;46(7):661-76. doi: 10.1080/15563650802178136. Clin Toxicol (Phila). 2008. PMID: 18608263 Review.
Cited by
-
Street drug abuse leading to critical illness.Intensive Care Med. 2004 Aug;30(8):1526-36. doi: 10.1007/s00134-004-2229-1. Epub 2004 Mar 4. Intensive Care Med. 2004. PMID: 14999443 Review.
-
Traumatic brain injury after a motor vehicle accident: fact or "fantasy"?Emerg Med J. 2001 Nov;18(6):458-9. doi: 10.1136/emj.18.6.458. Emerg Med J. 2001. PMID: 11696495 Free PMC article. No abstract available.
-
Behavioral analyses of GHB: receptor mechanisms.Pharmacol Ther. 2009 Jan;121(1):100-14. doi: 10.1016/j.pharmthera.2008.10.003. Epub 2008 Oct 29. Pharmacol Ther. 2009. PMID: 19010351 Free PMC article. Review.
-
GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Curr Neuropharmacol. 2015 Jan;13(1):47-70. doi: 10.2174/1570159X13666141210215423. Curr Neuropharmacol. 2015. PMID: 26074743 Free PMC article. Review.
-
Monocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept Study.J Clin Toxicol. 2011 Nov 10;1(2):1000105. doi: 10.4172/2161-0495.1000105. J Clin Toxicol. 2011. PMID: 24772380 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical